Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 123.70
-1.10 (-0.88%)
Jul 17, 2025, 5:38 PM CET
Galderma Group AG Company Description
Galderma Group AG operates as a dermatology company worldwide.
The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.
Its portfolio of flagship brands includes Actinica, Dysport/Azzalure, Alluzience, Restylane and Restylane Skinboosters, Sculptra, Cetaphil and Alastin, Soolantra, Epiduo and Epiduo Forte, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Mirvaso, Nemluvio, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology.
The company was founded in 1981 and is headquartered in Zug, Switzerland.
Galderma Group AG
| Country | Switzerland |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,545 |
| CEO | Flemming Ornskov |
Contact Details
Address: Zählerweg 10 Zug, 6300 Switzerland | |
| Phone | 41 58 455 85 92 |
| Website | galderma.com |
Stock Details
| Ticker Symbol | GALD |
| Exchange | SIX Swiss Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CH1335392721 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Flemming Ornskov M.B.A., M.P.H. | Chief Executive Officer and Director |
| Thomas J. W. Dittrich | Chief Financial Officer |
| Adrian Murphy | Head of Global Operations |
| Emil Ivanov | Head of Strategy, Investor Relations and ESG |
| Christian Marcoux | Chief Communications Officer |
| Allison Pinkham | Chief Human Resources Officer |